Year |
Citation |
Score |
2024 |
Coratti G, Bovis F, Pera MC, Civitello M, Rohwer A, Salmin F, Glanzman AM, Montes J, Pasternak A, De Sanctis R, Dunaway Young S, Duong T, Mizzoni I, Milev E, Sframeli M, et al. Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale Expanded. European Journal of Neurology. e16517. PMID 39392101 DOI: 10.1111/ene.16517 |
0.3 |
|
2024 |
Trucco F, Ridout D, Weststrate H, Scoto M, Rohwer A, Coratti G, Main ML, Mayhew AG, Montes J, De Sanctis R, Pane M, Pera MC, Sansone VA, Albamonte E, D'Amico A, et al. Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3. Neurology. Clinical Practice. 14: e200298. PMID 38932995 DOI: 10.1212/CPJ.0000000000200298 |
0.331 |
|
2024 |
Harding ER, Kanner CH, Pasternak A, Glanzman AM, Dunaway Young S, Rao AK, McDermott MP, Zolkipli-Cunningham Z, Day JW, Finkel RS, Darras BT, De Vivo DC, Montes J. Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility. Journal of Clinical Medicine. 13. PMID 38731167 DOI: 10.3390/jcm13092634 |
0.519 |
|
2024 |
Coratti G, Bovis F, Pera MC, Scoto M, Montes J, Pasternak A, Mayhew A, Muni-Lofra R, Duong T, Rohwer A, Dunaway Young S, Civitello M, Salmin F, Mizzoni I, Morando S, et al. Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study. European Journal of Neurology. e16309. PMID 38656662 DOI: 10.1111/ene.16309 |
0.369 |
|
2024 |
Wolfe A, Stimpson G, Ramsey D, Coratti G, Dunaway Young S, Mayhew A, Pane M, Rohwer A, Muni Lofra R, Duong T, O'Reilly E, Milev E, Civitello M, Sansone VA, D'Amico A, ... ... Montes J, et al. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of Neuromuscular Diseases. PMID 38427497 DOI: 10.3233/JND-230211 |
0.362 |
|
2023 |
Sadjadi R, Kelly K, Glanzman AM, Montes J, Linsenmayer M, Tellez M, Bartlett A, Heintzman S, Kolb SJ, Arnold WD, El-Sheikh B. Psychometric Evaluation of modified Spinal Muscular Atrophy Functional Rating Scale (SMAFRS) in adult patients using Rasch Analysis. Muscle & Nerve. PMID 36605016 DOI: 10.1002/mus.27785 |
0.31 |
|
2022 |
Cheng R, Feng J, Goodwin AM, Uher D, Rao AK, McDermott MP, De Vivo DC, Ewing Garber C, Montes J. Perceived Exertion is not a Substitute for Fatiguability in Spinal Muscular Atrophy. Muscle & Nerve. PMID 36484158 DOI: 10.1002/mus.27765 |
0.528 |
|
2021 |
Ardalan A, Yamane N, Rao AK, Montes J, Goldman S. Analysis of gait synchrony and balance in neurodevelopmental disorders using computer vision techniques. Health Informatics Journal. 27: 14604582211055650. PMID 34989252 DOI: 10.1177/14604582211055650 |
0.445 |
|
2021 |
Coratti G, Pera MC, Montes J, Pasternak A, Scoto M, Baranello G, Messina S, Dunaway Young S, Glanzman AM, Duong T, de Sanctis R, Mazzone ES, Milev E, Rohwer A, Civitello M, et al. Different trajectories in upper limb and gross motor function in spinal muscular atrophy. Muscle & Nerve. PMID 34327716 DOI: 10.1002/mus.27384 |
0.38 |
|
2021 |
Fragala-Pinkham M, Pasternak A, McDermott MP, Mirek E, Glanzman AM, Montes J, Dunaway Young S, Salazar R, Quigley J, Riley SO, Chiriboga CA, Finkel RS, Tennekoon G, Martens WB, De Vivo DC, et al. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy. Journal of Pediatric Rehabilitation Medicine. PMID 34275913 DOI: 10.3233/PRM-190664 |
0.301 |
|
2021 |
Fragala-Pinkham M, Pasternak A, McDermott MP, Mirek E, Glanzman AM, Montes J, Dunaway Young S, Salazar R, Quigley J, Riley SO, Chiriboga CA, Finkel RS, Tennekoon G, Martens WB, De Vivo DC, et al. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy. Journal of Pediatric Rehabilitation Medicine. PMID 34275913 DOI: 10.3233/PRM-190664 |
0.301 |
|
2021 |
Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Bishop KM, Foster R, Liu Y, Ramirez-Schrempp D, Schneider E, Bennett CF, Wong J, Farwell W. Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study. The Lancet. Child & Adolescent Health. PMID 34089650 DOI: 10.1016/S2352-4642(21)00100-0 |
0.311 |
|
2021 |
Montes J, Goodwin AM, McDermott MP, Uher D, Hernandez FM, Coutts K, Cocchi J, Hauschildt M, Cornett KM, Rao AK, Monani UR, Ewing Garber C, De Vivo DC. Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy. Annals of Clinical and Translational Neurology. PMID 33788421 DOI: 10.1002/acn3.51353 |
0.534 |
|
2020 |
Trucco F, Ridout D, Scoto M, Coratti G, Main ML, Lofra RM, Mayhew AG, Montes J, Pane M, Sansone V, Albamonte E, D'Amico A, Bertini E, Messina S, Bruno C, et al. Respiratory trajectories in type 2 and non-ambulant 3 Spinal muscular atrophy in the iSMAC cohort study. Neurology. PMID 33067401 DOI: 10.1212/WNL.0000000000011051 |
0.354 |
|
2020 |
Coratti G, Messina S, Lucibello S, Pera MC, Montes J, Pasternak A, Stat FB, Escudero JE, Mazzone ES, Mayhew A, Glanzman AM, Young SD, Salazar R, Duong T, Lofra RM, et al. Clinical variability in spinal muscular atrophy type III. Annals of Neurology. PMID 32926458 DOI: 10.1002/Ana.25900 |
0.432 |
|
2020 |
Rodriguez-Torres R, Fabiano J, Goodwin A, Rao AK, Kinirons S, De Vivo D, Montes J. Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy. Journal of Neuromuscular Diseases. PMID 32925091 DOI: 10.3233/Jnd-200550 |
0.6 |
|
2020 |
Coratti G, Pera MC, Lucibello S, Montes J, Pasternak A, Mayhew A, Glanzman AM, Young SD, Pane M, Scoto M, Messina S, Goemans N, Osorio AN, Pedemonte M, Sansone V, et al. Age and baseline values predict 12 and 24-month functional changes in type 2 SMA. Neuromuscular Disorders : Nmd. PMID 32900576 DOI: 10.1016/J.Nmd.2020.07.005 |
0.335 |
|
2020 |
Montes J, Yoon LH. Commentary on "Stander Use in Spinal Muscular Atrophy: Results From a Large Natural History Database". Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 32: 242. PMID 32604368 DOI: 10.1097/Pep.0000000000000722 |
0.433 |
|
2020 |
Mercuri E, Lucibello S, Perulli M, Coratti G, de Sanctis R, Pera MC, Pane M, Montes J, de Vivo DC, Darras BT, Kolb SJ, Finkel RS. Longitudinal natural history of type I spinal muscular atrophy: a critical review. Orphanet Journal of Rare Diseases. 15: 84. PMID 32248834 DOI: 10.1186/S13023-020-01356-1 |
0.389 |
|
2020 |
Young SD, Montes J, Salazar R, Glanzman AM, Pasternak A, Mirek E, Martens W, Finkel RS, Darras BT, De Vivo DC. Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1. Journal of Neuromuscular Diseases. PMID 32083590 DOI: 10.3233/Jnd-190462 |
0.422 |
|
2019 |
Goodwin AM, Cornett KMD, McKay MJ, Burns J, Ewing Garber C, De Vivo DC, Montes J. Limitations of six-minute Walk Test Reference Values for Spinal Muscular Atrophy. Muscle & Nerve. PMID 31884700 DOI: 10.1002/Mus.26794 |
0.478 |
|
2019 |
Messina S, Frongia AL, Antonaci L, Pera MC, Coratti G, Pane M, Pasternak A, Civitello M, Montes J, Mayhew A, Finkel R, Muntoni F, Mercuri E. A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy. Neuromuscular Disorders : Nmd. PMID 31791871 DOI: 10.1016/J.Nmd.2019.10.001 |
0.349 |
|
2019 |
Goldman S, McCullough AK, Young SD, Mueller C, Stahl A, Zoeller A, Abbruzzese LD, Rao AK, Montes J. Quantitative gait assessment in children with 16p11.2 syndrome. Journal of Neurodevelopmental Disorders. 11: 26. PMID 31656164 DOI: 10.1186/s11689-019-9286-9 |
0.473 |
|
2019 |
Montes J, Dunaway Young S, Mazzone ES, Pasternak A, Glanzman AM, Finkel RS, Darras BT, Muntoni F, Mercuri E, De Vivo DC, Bishop KM, Schneider E, Bennett CF, Foster R, Farwell W, et al. Nusinersen Improves Walking Distance and Reduces Fatigue in Later-Onset SMA. Muscle & Nerve. PMID 31298747 DOI: 10.1002/Mus.26633 |
0.456 |
|
2019 |
Darras BT, Chiriboga CA, Iannaccone ST, Swoboda KJ, Montes J, Mignon L, Xia S, Bennett CF, Bishop KM, Shefner JM, Green AM, Sun P, Bhan I, Gheuens S, Schneider E, et al. Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies. Neurology. PMID 31019106 DOI: 10.1212/Wnl.0000000000007527 |
0.438 |
|
2019 |
Bartels B, Montes J, van der Pol WL, de Groot JF. Physical exercise training for type 3 spinal muscular atrophy. The Cochrane Database of Systematic Reviews. 3: CD012120. PMID 30821348 DOI: 10.1002/14651858.Cd012120.Pub2 |
0.36 |
|
2019 |
Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, Main M, Mayhew A, Muni Lofra R, Dunaway Young S, Glanzman AM, Duong T, Pasternak A, Ramsey D, Darras B, et al. Revised Upper Limb Module for Spinal Muscular Atrophy: 12 month changes. Muscle & Nerve. PMID 30677148 DOI: 10.1002/Mus.26419 |
0.466 |
|
2019 |
Goodwin AM, Montes J, Ensari I, Hernandez FM, Coutts K, Rao AK, Garber CE. Relationship Between Muscle Deoxygenation And Workload At Peak Exercise In Healthy Adults Using Near-infrared Spectroscopy Medicine & Science in Sports & Exercise. 51: 300. DOI: 10.1249/01.Mss.0000561407.14368.E4 |
0.488 |
|
2019 |
Kirschner J, Darras B, Farrar M, Mercuri E, Chiriboga C, Kuntz N, Shieh P, Tulinius M, Montes J, Reyna S, Gambino G, Foster R, Bhan I, Wong J, Farwell W. P.352Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): results from the SHINE study Neuromuscular Disorders. 29. DOI: 10.1016/J.Nmd.2019.06.514 |
0.396 |
|
2019 |
Ramsey D, Scoto M, Mayhew A, Lofra RM, Main M, Milev E, Mazzone E, Montes J, Glanzman A, Pasternak A, Duong T, Civitello M, Coratti G, Straub V, Day J, et al. P.220The revised Hammersmith scale (RHS) for spinal muscular atrophy: longitudinal trajectories in a large international cohort of patients with type 2 and 3 SMA Neuromuscular Disorders. 29. DOI: 10.1016/J.Nmd.2019.06.334 |
0.441 |
|
2019 |
Kirschner J, Darras BT, Farrar MA, Mercuri E, Chiriboga CA, Kuntz NL, Shieh PB, Tulinius M, Montes J, Reyna SP, Gambino G, Foster R, Bhan I, Wong J, Farwell W. Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): Results from the shine study Journal of the Neurological Sciences. 405: 248-249. DOI: 10.1016/J.Jns.2019.10.1272 |
0.387 |
|
2018 |
Young SD, Montes J, Kramer SS, Podwika B, Rao AK, De Vivo DC. Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study. Journal of Neuromuscular Diseases. PMID 30562906 DOI: 10.3233/Jnd-180342 |
0.609 |
|
2018 |
Krosschell KJ, Bosch M, Nelson L, Duong T, Lowes LP, Alfano LN, Benjamin D, Carry TB, Devine G, Kelley C, Gadekan R, Malkus EC, Pasternak A, Provance-Orr S, Roemeiser-Logan L, ... ... Montes J, et al. Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study. Journal of Neuromuscular Diseases. PMID 30223401 DOI: 10.3233/Jnd-180327 |
0.334 |
|
2018 |
Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, et al. Ambulatory function in spinal muscular atrophy: Age-related patterns of progression. Plos One. 13: e0199657. PMID 29944707 DOI: 10.1371/Journal.Pone.0199657 |
0.33 |
|
2018 |
Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, et al. Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function. Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 30: 209-215. PMID 29924070 DOI: 10.1097/Pep.0000000000000515 |
0.455 |
|
2018 |
Glanzman AM, Mazzone ES, Young SD, Gee R, Rose K, Mayhew A, Nelson L, Yun C, Alexander K, Darras BT, Zolkipli-Cunningham Z, Tennekoon G, Day JW, Finkel RS, Mercuri E, ... ... Montes J, et al. Evaluator Training and Reliability for SMA Global Nusinersen Trials1. Journal of Neuromuscular Diseases. 5: 159-166. PMID 29865090 DOI: 10.3233/Jnd-180301 |
0.328 |
|
2018 |
Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, Iannaccone ST, Kirschner J, Kuntz NL, Saito K, Shieh PB, Tulinius M, Mazzone ES, Montes J, Bishop KM, et al. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. The New England Journal of Medicine. 378: 625-635. PMID 29443664 DOI: 10.1056/Nejmoa1710504 |
0.366 |
|
2017 |
Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders : Nmd. PMID 29305137 DOI: 10.1016/J.Nmd.2017.11.004 |
0.354 |
|
2017 |
Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Meyer OH, Simonds AK, Schroth MK, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular Disorders : Nmd. PMID 29290580 DOI: 10.1016/J.Nmd.2017.11.005 |
0.358 |
|
2017 |
Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K, Servais L, Tizzano E, Topaloglu H, Tulinius M, Montes J, Glanzman AM, Bishop K, et al. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. The New England Journal of Medicine. 377: 1723-1732. PMID 29091570 DOI: 10.1056/Nejmoa1702752 |
0.361 |
|
2017 |
Montes J, Young SD, Mazzone E, Main M. Neuromuscular Disorders : Nmd. PMID 28917631 DOI: 10.1016/J.Nmd.2017.07.005 |
0.374 |
|
2017 |
Bishop KM, Montes J, Finkel RS. Motor Milestone Assessment of Infants with Spinal Muscular Atrophy Using the Hammersmith Infant Neurological Exam - Part 2: Experience from a Nusinersen Clinical Study. Muscle & Nerve. PMID 28556387 DOI: 10.1002/Mus.25705 |
0.376 |
|
2017 |
Pera MC, Coratti G, Forcina N, Mazzone ES, Scoto M, Montes J, Pasternak A, Mayhew A, Messina S, Sframeli M, Main M, Lofra RM, Duong T, Ramsey D, Dunaway S, et al. Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy. Bmc Neurology. 17: 39. PMID 28231823 DOI: 10.1186/S12883-017-0790-9 |
0.468 |
|
2017 |
Ramsey D, Scoto M, Mayhew A, Main M, Mazzone ES, Montes J, de Sanctis R, Dunaway Young S, Salazar R, Glanzman AM, Pasternak A, Quigley J, Mirek E, Duong T, Gee R, et al. Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool. Plos One. 12: e0172346. PMID 28222119 DOI: 10.1371/Journal.Pone.0172346 |
0.408 |
|
2017 |
Kirschner J, Mercuri E, Finkel RS, Chiriboga CA, Kuntz N, Darras BT, Shieh PB, Saito K, Vivo DCD, Mazzone ES, Montes J, Yang Q, Zhong ZJ, Gheuens S, Bennett CF, et al. Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study Neuropediatrics. 48. DOI: 10.1055/S-0037-1603574 |
0.387 |
|
2017 |
Finkel R, Kuntz N, Mercuri E, Muntoni F, Chiriboga CA, Darras B, Topaloglu H, Montes J, Su J, Zhong ZJ, Gheuens S, Bennett CF, Schneider E, Farwell W. Interim Efficacy and Safety Results from the Phase 3 ENDEAR Study of Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA) Neuropediatrics. 48. DOI: 10.1055/S-0037-1602912 |
0.377 |
|
2017 |
Mercuri E, Finkel R, Kirschner J, Chiriboga C, Kuntz N, Darras B, Shieh P, Saito K, De Vivo D, Mazzone E, Montes J, Yang Q, Zhong Z, Gheuens S, Bennett C, et al. Interim analysis of the phase 3 CHERISH study evaluating nusinersen in patients with later-onset spinal muscular atrophy (SMA): Primary and descriptive secondary endpoints European Journal of Paediatric Neurology. 21: e15. DOI: 10.1016/J.Ejpn.2017.04.1220 |
0.42 |
|
2017 |
Finkel R, Kuntz N, Mercuri E, Chiriboga C, Darras B, Topaloglu H, Montes J, Su J, Zhong Z, Gheuens S, Bennett C, Schneider E, Farwell W. Efficacy and safety of nusinersen in infants with spinal muscular atrophy (SMA): Final results from the phase 3 ENDEAR study European Journal of Paediatric Neurology. 21: e14-e15. DOI: 10.1016/J.Ejpn.2017.04.1219 |
0.372 |
|
2016 |
Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F, Hung G, Schneider E, Norris DA, Xia S, Bennett CF, Bishop KM. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet (London, England). PMID 27939059 DOI: 10.1016/S0140-6736(16)31408-8 |
0.449 |
|
2016 |
Montes J, Zanotto D, Dunaway Young S, Salazar R, De Vivo DC, Agrawal S. Gait Assessment with SoleSound Instrumented Footwear in Spinal Muscular Atrophy. Muscle & Nerve. PMID 27863443 DOI: 10.1002/Mus.25484 |
0.474 |
|
2016 |
De Sanctis R, Coratti G, Pasternak A, Montes J, Pane M, Mazzone ES, Young SD, Salazar R, Quigley J, Pera MC, Antonaci L, Lapenta L, Glanzman AM, Tiziano D, Muntoni F, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscular Disorders : Nmd. PMID 27769560 DOI: 10.1016/J.Nmd.2016.10.002 |
0.315 |
|
2016 |
Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Dunaway Young S, Salazar R, De Sanctis R, Pasternak A, Glanzman A, Coratti G, Civitello M, Forcina N, Gee R, Duong T, et al. Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle & Nerve. PMID 27701745 DOI: 10.1002/Mus.25430 |
0.475 |
|
2016 |
Blumenschine M, Montes J, Rao AK, Engelstad K, De Vivo DC. Analysis of Gait Disturbance in Glut 1 Deficiency Syndrome. Journal of Child Neurology. PMID 27511993 DOI: 10.1177/0883073816661662 |
0.542 |
|
2016 |
Pasternak A, Sideridis G, Fragala-Pinkham M, Glanzman AM, Montes J, Dunaway S, Salazar R, Quigley J, Pandya S, O'Riley S, Greenwood J, Chiriboga C, Finkel R, Tennekoon G, Martens WB, et al. Rasch analysis of the pediatric evaluation of disability inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy. Muscle & Nerve. PMID 27121348 DOI: 10.1002/Mus.25164 |
0.38 |
|
2016 |
Young SD, Montes J, Kramer SS, Marra J, Salazar R, Cruz R, Chiriboga CA, Garber CE, De Vivo DC. Six-Minute Walk Test is Reliable and Valid in Spinal Muscular Atrophy. Muscle & Nerve. PMID 27015431 DOI: 10.1002/Mus.25120 |
0.448 |
|
2016 |
Chiriboga CA, Swoboda KJ, Darras BT, Iannaccone ST, Montes J, De Vivo DC, Norris DA, Bennett CF, Bishop KM. Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy. Neurology. PMID 26865511 DOI: 10.1212/Wnl.0000000000002445 |
0.448 |
|
2016 |
Ramsey D, Scoto M, Mayhew A, Main M, Mazzone E, Montes J, Dunaway S, Salazar R, Glanzman A, Pasternak A, Duong T, Gee R, Civitello M, Bushby K, Day J, et al. Revised Hammersmith scale for spinal muscular atrophy: Longitudinal changes over six and twelve months in a large international cohort Neuromuscular Disorders. 26. DOI: 10.1016/J.Nmd.2016.06.071 |
0.41 |
|
2016 |
Dunaway Young S, Montes J, Salazar R, Glanzman A, Pasternak A, Quigley J, Ciurylo E, Riley S, Martens W, Gee R, Duong T, Civitello M, Chiriboga C, Tennekoon G, Day J, et al. Should motor function determine the timing of scoliosis surgery in spinal muscular atrophy? Neuromuscular Disorders. 26: S104. DOI: 10.1016/J.Nmd.2016.06.070 |
0.411 |
|
2016 |
Bartels B, Montes J, van der Pol WL, de Groot JF. Skeletal muscle training for spinal muscular atrophy type 3 Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.Cd012120 |
0.39 |
|
2015 |
Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, Carr B, Cruz R, Strauss NE, Sproule D, De Vivo DC. Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? Journal of Neuromuscular Diseases. 2: 463-470. PMID 27858749 DOI: 10.3233/Jnd-150101 |
0.374 |
|
2015 |
Mercuri E, Finkel R, Montes J, Mazzone ES, Sormani MP, Main M, Ramsey D, Mayhew A, Glanzman AM, Dunaway S, Salazar R, Pasternak A, Quigley J, Pane M, Pera MC, et al. Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials. Neuromuscular Disorders : Nmd. PMID 26776503 DOI: 10.1016/J.Nmd.2015.10.006 |
0.32 |
|
2015 |
Mazzone E, Montes J, Main M, Mayhew A, Ramsey D, Glanzman AM, Dunaway S, Salazar R, Pasternak A, Quigley J, Pane M, Pera MC, Scoto M, Messina S, Sframeli M, et al. Old measures and new scores in spinal muscular atrophy patients. Muscle & Nerve. 52: 435-7. PMID 26111847 DOI: 10.1002/Mus.24748 |
0.444 |
|
2015 |
Montes J, Glanzman AM, Mazzone ES, Martens WB, Dunaway S, Pasternak A, Riley SO, Quigley J, Pandya S, De Vivo DC, Kaufmann P, Chiriboga CA, Finkel RS, Tennekoon GI, Darras BT, et al. SMA functional composite score: A functional measure in spinal muscular atrophy. Muscle & Nerve. PMID 25846132 DOI: 10.1002/Mus.24670 |
0.434 |
|
2015 |
Sivo S, Mazzone E, Antonaci L, De Sanctis R, Fanelli L, Palermo C, Montes J, Pane M, Mercuri E. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscular Disorders : Nmd. 25: 212-5. PMID 25500010 DOI: 10.1016/J.Nmd.2014.11.008 |
0.442 |
|
2015 |
Alter AS, Engelstad K, Hinton VJ, Montes J, Pearson TS, Akman CI, De Vivo DC. Long-term clinical course of Glut1 deficiency syndrome. Journal of Child Neurology. 30: 160-9. PMID 24789115 DOI: 10.1177/0883073814531822 |
0.303 |
|
2015 |
Leaffer E, Hinton V, Salazar R, Montes J, Dunaway Young S, Holuba LaMarca N, De Vivo D. Pediatrics-1Spinal Muscular Atrophy Type I: Cases of Normal Cognitive Function Despite having Limited Motor Function and Physical-Environmental Interaction Archives of Clinical Neuropsychology. 30: 481.1-481. DOI: 10.1093/Arclin/Acv046.17 |
0.39 |
|
2015 |
Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Dunaway S, Pasternak A, Salazar R, Bushby K, Finkel R, Mercuri E, Muntoni F. Revised Hammersmith scale for spinal muscular atrophy Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.044 |
0.419 |
|
2014 |
Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, Carr B, Strauss NE, Sproule D, De Vivo DC. A Randomized, Controlled Clinical Trial of Exercise in Patients with Spinal Muscular Atrophy: Methods and Baseline Characteristics. Journal of Neuromuscular Diseases. 1: 151-161. PMID 27858768 DOI: 10.3233/Jnd-140004 |
0.416 |
|
2014 |
Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, Kang PB, Foley AR, Yang ML, Martens WB, Oskoui M, Glanzman AM, Flickinger J, Montes J, Dunaway S, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 83: 810-7. PMID 25080519 DOI: 10.1212/Wnl.0000000000000741 |
0.446 |
|
2014 |
Dunaway S, Montes J, Garber CE, Carr B, Kramer SS, Kamil-Rosenberg S, Strauss N, Sproule D, De Vivo DC. Performance of the timed "up & go" test in spinal muscular atrophy. Muscle & Nerve. 50: 273-7. PMID 24375426 DOI: 10.1002/Mus.24153 |
0.41 |
|
2014 |
Montes J, Dunaway S, Garber CE, Chiriboga CA, De Vivo DC, Rao AK. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3. Muscle & Nerve. 50: 34-9. PMID 24122959 DOI: 10.1002/Mus.24081 |
0.608 |
|
2014 |
Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F. P74 Improving standards of care and translational research in spinal muscular atrophy (SMA) – functional scales Neuromuscular Disorders. 24. DOI: 10.1016/S0960-8966(14)70090-2 |
0.393 |
|
2014 |
Darras B, Chiriboga C, Swoboda K, Iannaccone S, Montes J, Castro D, Holuba N, Raush N, Visyak N, Dunaway S, Trussell D, Pasternak A, Neilson L, Vivo DD, McGuire D, et al. G.O.18 Neuromuscular Disorders. 24: 920. DOI: 10.1016/J.Nmd.2014.06.417 |
0.311 |
|
2014 |
Finkel RS, Day J, Chiriboga C, Vasjar J, Cook D, Watson K, Paulose S, McMillian L, Cruz R, Montes J, Vivo DCD, Yamashita M, McGuire D, Alexander K, Norris D, et al. G.O.17 Neuromuscular Disorders. 24: 920. DOI: 10.1016/J.Nmd.2014.06.416 |
0.362 |
|
2014 |
Mazzone E, Mayhew A, Main M, Montes J, Ramsey D, Scoto M, Pane M, Bushby K, Finkel R, Muntoni F, Mercuri E. T.P.37 Neuromuscular Disorders. 24: 905. DOI: 10.1016/J.Nmd.2014.06.368 |
0.357 |
|
2014 |
Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F. T.P.35 Neuromuscular Disorders. 24: 904. DOI: 10.1016/J.Nmd.2014.06.366 |
0.358 |
|
2013 |
Montes J, Blumenschine M, Dunaway S, Alter AS, Engelstad K, Rao AK, Chiriboga CA, Sproule DM, De Vivo DC. Weakness and fatigue in diverse neuromuscular diseases. Journal of Child Neurology. 28: 1277-83. PMID 23847297 DOI: 10.1177/0883073813493663 |
0.618 |
|
2013 |
Montes J, McIsaac TL, Dunaway S, Kamil-Rosenberg S, Sproule D, Garber CE, De Vivo DC, Rao AK. Falls and spinal muscular atrophy: exploring cause and prevention. Muscle & Nerve. 47: 118-23. PMID 23042039 DOI: 10.1002/Mus.23656 |
0.737 |
|
2013 |
Dunaway S, Montes J, O'Hagen J, Sproule DM, Vivo DC, Kaufmann P. Independent mobility after early introduction of a power wheelchair in spinal muscular atrophy. Journal of Child Neurology. 28: 576-82. PMID 22772161 DOI: 10.1177/0883073812449383 |
0.4 |
|
2013 |
Swoboda K, Chiriboga C, Darras B, Iannaccone S, Montes J, Rausch N, Parad R, Johnson S, Vivo DD, Norris D, Alexander K, Bennet FC, Bishop K. O.9 First-in-human phase I study to assess safety, tolerability and dose for intrathecal injection of ISIS-SMNRx in SMA patients Neuromuscular Disorders. 23: 797-798. DOI: 10.1016/J.Nmd.2013.06.559 |
0.304 |
|
2012 |
Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M, Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB, Montes J, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology. 79: 1889-97. PMID 23077013 DOI: 10.1212/Wnl.0B013E318271F7E4 |
0.428 |
|
2012 |
Dunaway S, Montes J, Ryan PA, Montgomery M, Sproule DM, De Vivo DC. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report. Journal of Child Neurology. 27: 779-85. PMID 22156787 DOI: 10.1177/0883073811425423 |
0.463 |
|
2012 |
Montes J, McIsaac T, Dunaway S, Kamil-Rosenberg S, Sproule D, Garber C, De Vivo D, Rao A. Falls and Spinal Muscular Atrophy (SMA): Exploring Cause and Prevention (P03.177) Neurology. 78: P03.177-P03.177. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.177 |
0.742 |
|
2011 |
Glanzman AM, McDermott MP, Montes J, Martens WB, Flickinger J, Riley S, Quigley J, Dunaway S, O'Hagen J, Deng L, Chung WK, Tawil R, Darras BT, Yang M, Sproule D, et al. Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 23: 322-6. PMID 22090068 DOI: 10.1097/Pep.0B013E3182351F04 |
0.391 |
|
2011 |
Glanzman AM, O'Hagen JM, McDermott MP, Martens WB, Flickinger J, Riley S, Quigley J, Montes J, Dunaway S, Deng L, Chung WK, Tawil R, Darras BT, De Vivo DC, Kaufmann P, et al. Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. Journal of Child Neurology. 26: 1499-507. PMID 21940700 DOI: 10.1177/0883073811420294 |
0.414 |
|
2011 |
Sproule DM, Montgomery MJ, Punyanitya M, Shen W, Dashnaw S, Montes J, Dunaway S, Finkel R, Darras B, Vivo DC, Kaufmann P. Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. Journal of Child Neurology. 26: 1252-9. PMID 21572051 DOI: 10.1177/0883073811405053 |
0.374 |
|
2011 |
Montes J, Dunaway S, Montgomery MJ, Sproule D, Kaufmann P, De Vivo DC, Rao AK. Fatigue leads to gait changes in spinal muscular atrophy. Muscle & Nerve. 43: 485-8. PMID 21404286 DOI: 10.1002/Mus.21917 |
0.604 |
|
2011 |
Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Archives of Neurology. 68: 779-86. PMID 21320981 DOI: 10.1001/Archneurol.2010.373 |
0.43 |
|
2011 |
Sproule DM, Punyanitya M, Shen W, Dashnaw S, Martens B, Montgomery M, Montes J, Battista V, Finkel R, Darras B, De Vivo DC, Kaufmann P. Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. Journal of Child Neurology. 26: 309-17. PMID 20929908 DOI: 10.1177/0883073810380457 |
0.36 |
|
2010 |
King W, Kissel JT, Montes J, De Vivo DC, Finkel RS. Six-minute walk test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 75: 1121-2; author reply. PMID 20855858 DOI: 10.1212/WNL.0b013e3181f00304 |
0.364 |
|
2010 |
Sproule DM, Montes J, Dunaway S, Montgomery M, Battista V, Koenigsberger D, Martens B, Shen W, Punyanitya M, Benton M, Butler H, Caracciolo J, Mercuri E, Finkel R, Darras B, et al. Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscular Disorders : Nmd. 20: 448-52. PMID 20610154 DOI: 10.1016/J.Nmd.2010.05.013 |
0.332 |
|
2010 |
Sproule DM, Montes J, Dunaway SL, Montgomery M, Battista V, Shen W, Punyanitya M, De Vivo DC, Kaufmann P. Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy. Journal of Child Neurology. 25: 1348-54. PMID 20388937 DOI: 10.1177/0883073810365185 |
0.336 |
|
2010 |
Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, De Vivo DC, Kaufmann P, Finkel RS, et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 74: 833-8. PMID 20211907 DOI: 10.1212/Wnl.0B013E3181D3E308 |
0.463 |
|
2010 |
Dunaway S, Montes J, Montgomery M, Battista V, Koo B, Marra J, De Vivo DC, Hynan LS, Iannaccone ST, Kaufmann P. Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscular Disorders : Nmd. 20: 162-5. PMID 20074950 DOI: 10.1016/J.Nmd.2009.12.002 |
0.329 |
|
2009 |
Montes J, Gordon AM, Pandya S, De Vivo DC, Kaufmann P. Clinical outcome measures in spinal muscular atrophy. Journal of Child Neurology. 24: 968-78. PMID 19509409 DOI: 10.1177/0883073809332702 |
0.619 |
|
2008 |
Chen A, Montes J, Mitsumoto H. The role of exercise in amyotrophic lateral sclerosis. Physical Medicine and Rehabilitation Clinics of North America. 19: 545-57, ix-x. PMID 18625415 DOI: 10.1016/J.Pmr.2008.02.003 |
0.316 |
|
2007 |
Gordon PH, Cheng B, Montes J, Doorish C, Albert SM, Mitsumoto H. Outcome measures for early phase clinical trials. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 270-3. PMID 17852017 DOI: 10.1080/17482960701547958 |
0.349 |
|
2007 |
Montes J, Cheng B, Diamond B, Doorish C, Mitsumoto H, Gordon PH. The Timed Up and Go test: predicting falls in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 292-5. PMID 17852012 DOI: 10.1080/17482960701435931 |
0.334 |
|
2007 |
Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, Mao X, Hays AP, Floyd AG, Battista V, Montes J, Hayes S, Dashnaw S, Kaufmann P, Gordon PH, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 68: 1402-10. PMID 17452585 DOI: 10.1212/01.Wnl.0000260065.57832.87 |
0.323 |
|
Show low-probability matches. |